4.6 Article

Geographic epidemiology of cardiometabolic risk factors in middle class urban residents in India: cross-sectional study

Journal

JOURNAL OF GLOBAL HEALTH
Volume 5, Issue 1, Pages 150-162

Publisher

UNIV EDINBURGH, GLOBAL HEALTH SOC
DOI: 10.7189/jogh.05.010411

Keywords

-

Funding

  1. South Asian Society of Atherosclerosis and Thrombosis, Bangalore, India

Ask authors/readers for more resources

Objective To determine epidemiology of cardiovascular risk factors according to geographic distribution and macrolevel social development index among urban middle class subjects in India. Methods We performed cross-sectional surveys in 11 cities in India during years 2005-2009. 6198 subjects aged 20-75 years (men 3426, women 2772, response 62%) were evaluated for cardiovascular risk factors. Cities were grouped according to geographic distribution into northern (3 cities, n = 1321), western (2 cities, n = 1814), southern (3 cities, n = 1237) and eastern (3 cities, n = 1826). They were also grouped according to human social development index into low (3 cities, n = 1794), middle (5 cities, n = 2634) and high (3 cities, n = 1825). Standard definitions were used to determine risk factors. Differences in risk factors were evaluated using chi(2) test. Trends were examined by least squares regression. Findings Age-adjusted prevalence (95% confidence intervals) of various risk factors was: low physical activity 42.1% (40.9-43.3), high dietary fat 49.9% (47.8-52.0), low fruit/vegetables 26.9% (25.8-28.0), smoking 10.1% (9.1-11.1), smokeless tobacco use 9.8% (9.1-10.5), overweight 42.9% (41.7-44.1), obesity 11.6% (10.8-12.4), high waist circumference 45.5% (44.3-46.7), high waist-hip ratio 75.7% (74.7-76.8), hypertension 31.6% (30.4-32.8), hypercholesterolemia 25.0% (23.9-26.9), low HDL cholesterol 42.5% (41.3-43.7), hypertriglyceridemia 36.9% (35.7-38.1), diabetes 15.7% (14.8-16.6), and metabolic syndrome 35.7% (34.5-36.9). Compared with national average, prevalence of most risk factors was not significantly different in various geographic regions, however, cities in eastern region had significantly lower prevalence of overweight, hypertension, hypercholesterolemia, diabetes and metabolic syndrome compared with other regions (P < 0.05 for various comparisons). It was also observed that cities with low human social development index had lowest prevalence of these risk factors in both sexes (P < 0.05). Conclusions Urban middle-class men and women in eastern region of India have significantly lower cardiometabolic risk factors compared to northern, western and southern regions. Low human social development index cities have lower risk factor prevalence.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Peripheral Vascular Disease

May Measurement Month 2019 The Global Blood Pressure Screening Campaign of the International Society of Hypertension

Thomas Beaney, Aletta E. Schutte, George S. Stergiou, Claudio Borghi, Dylan Burger, Fadi Charchar, Suzie Cro, Alejandro Diaz, Albertino Damasceno, Walter Espeche, Arun Pulikkottil Jose, Nadia Khan, Yoshihiro Kokubo, Anuj Maheshwari, Marcos J. Marin, Arun More, Dinesh Neupane, Peter Nilsson, Mansi Patil, Dorairaj Prabhakaran, Agustin Ramirez, Pablo Rodriguez, Markus Schlaich, Ulrike M. Steckelings, Maciej Tomaszewski, Thomas Unger, Richard Wainford, Jiguang Wang, Bryan Williams, Neil R. Poulter

HYPERTENSION (2020)

Article Pharmacology & Pharmacy

Effects of empagliflozin on proinflammatory cytokines and other coronary risk factors in patients with type 2 diabetes mellitus: A single-arm real-world observation

Ram B. Singh, Ghizal Fatima, Puneet Kumar, Jan Fedacko, Viliam Mojto, Adrian Isaza, Nar SinghVerma, Anuj Maheshwari, Shashank Joshi, Banshi Saboo, Manoj Saxena

Summary: This real-world observation study shows that treatment with EMPA in patients with diabetes can significantly reduce markers of inflammation, blood sugar, oxidative stress, uric acid, and blood pressure, while increasing levels of antioxidant vitamins and nitrite. Further randomized controlled intervention trials are needed to confirm these findings.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2021)

Article Health Care Sciences & Services

Evaluating Glycemic Control in Patients of South Asian Origin With Type 2 Diabetes Using a Digital Therapeutic Platform: Analysis of Real-World Data

Arjun Krishnakumar, Ritika Verma, Rajeev Chawla, Aravind Sosale, Banshi Saboo, Shilpa Joshi, Maaz Shaikh, Abhishek Shah, Siddhesh Kolwankar, Vinod Mattoo

Summary: This study investigated the effectiveness of the Wellthy CARE digital therapeutic in improving glycemic control in a group of 102 patients with type 2 diabetes from India over a 16-week period. The results showed a significant reduction in HbA(1c), FBG, and PPBG levels, with higher program engagement leading to better outcomes in glycemic control.

JOURNAL OF MEDICAL INTERNET RESEARCH (2021)

Review Endocrinology & Metabolism

Steroid use during COVID-19 infection and hyperglycemia - What a physician should know

Aravind Sosale, Bhavana Sosale, Jothydev Kesavadev, Manoj Chawla, Sanjay Reddy, Banshi Saboo, Anoop Misra

Summary: This review aims to raise awareness among physicians on the challenges of steroid use and hyperglycemia during the COVID-19 pandemic. It provides guidance for managing hyperglycemia and highlights the importance of effective management during the current health crisis.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2021)

Article Endocrinology & Metabolism

QTc prolongation Safety and Effectiveness of Teneligliptin in Indian patients with type 2 Diabetes Mellitus: A real world study (QSET 2)

Banshi Saboo, Sujoy Ghosh, Mangesh Tiwaskar, Rajeev Chawla

Summary: Teneligliptin did not cause QTc interval prolongation and was significantly effective in improving glycemic control in Indian Type 2 Diabetes Mellitus patients.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2021)

Article Endocrinology & Metabolism

Variations in glycated haemoglobin with age among individuals with normal glucose tolerance: Implications for diagnosis and treatment-Results from the ICMR-INDIAB population-based study (INDIAB-12)

Mohan Deepa, Ranjit Mohan Anjana, Ranjit Unnikrishnan, Rajendra Pradeepa, Ashok Kumar Das, Sri Venkata Madhu, Paturi Vishnupriya Rao, Shashank Joshi, Banshi Saboo, Ajay Kumar, Anil Bhansali, Arvind Gupta, Sarita Bajaj, Nirmal Elangovan, Ulagamathesan Venkatesan, Radhakrishnan Subashini, Tanvir Kaur, R. S. Dhaliwal, Nikhil Tandon, Viswanathan Mohan

Summary: The study showed that HbA1c levels increase gradually with age, from 5.16±0.71% (33 mmol/mol) in the 20-29 age group to 5.49±0.69% (37 mmol/mol) in the 70+ age group. For every decadal increase in age, there was a 0.08% increase in HbA1c, with a more significant increase in females (0.10% vs. males: 0.06%) and urban population (urban: 0.10% vs. rural: 0.08%).

ACTA DIABETOLOGICA (2022)

Article Endocrinology & Metabolism

Clinical Profile of Long-term Survivors and Nonsurvivors with Type 1 Diabetes in India

Viswanathan Mohan, Coimbatore Subramanian Shanthi Rani, Banshi Saboo, Satinath Mukhopadhyay, Sudip Chatterjee, Panneerselvam Dharmarajan, Sunil Gupta, Sharad Pendsey, Jha Chandrakanta, Ganesan Umasankari, Anandakumar Amutha, Sheryl Salis, Supriya Datta, Prasanna Kumar Gupta, Philips Routray, Saravanan Jebarani, Nadiminty Ganapathi Sastry, Ulagamathesan Venkatesan, Ranjit Mohan Anjana, Ranjit Unnikrishnan

Summary: In this study comparing long-term survivors and nonsurvivors with type 1 diabetes in India, it was found that survivors had better glycemic control, blood pressure control, lipid profiles, and lower prevalence of complications. Non-survivors had higher rates of diabetic retinopathy, CKD, neuropathy, PVD, and CAD, with CAD and renal failure being the most common causes of death.

DIABETES TECHNOLOGY & THERAPEUTICS (2022)

Review Endocrinology & Metabolism

A prospective multicentre open label study to assess effect of Teneligliptin on glycemic control through parameters of time in range (TIR) Metric using continuous glucose monitoring (TOP-TIR study)

Banshi Saboo, Suhas Erande, A. G. Unnikrishnan

Summary: This study assessed the effect of Teneligliptin on glycemic control and variability. The results showed that Teneligliptin significantly reduced glycemic variability and improved control over hyperglycemic state in patients.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2022)

Article Endocrinology & Metabolism

Humoral antibody kinetics with ChAdOx1-nCOV (Covishield™) and BBV-152 (Covaxin™) vaccine among Indian Healthcare workers: A 6-month longitudinal cross-sectional Coronavirus Vaccine-induced antibody titre (COVAT) study

Awadhesh Kumar Singh, Sanjeev Ratnakar Phatak, Ritu Singh, Kingshuk Bhattacharjee, Nagendra Kumar Singh, Arvind Gupta, Arvind Sharma

Summary: According to this study, there is a decline in humoral antibody levels after six months of receiving either Covishield or Covaxin vaccines against SARS-CoV-2 in India. Covishield recipients had higher antibody levels compared to Covaxin recipients, but there was a significant decrease in antibody titers with Covishield at six months, while there was no decline with Covaxin.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2022)

Review Endocrinology & Metabolism

Time-in-range and frequency of continuous glucose monitoring: Recommendations for South Asia

Jothydev Kesavadev, Anoop Misra, Banshi Saboo, Sanjay Agarwal, Aravind Sosale, Shashank R. Joshi, Akhtar Hussain, Noel Somasundaram, Abdul Basit, Pratik Choudhary, Sidartawan Soegondo

Summary: The prevalence of diabetes is high in South Asia, posing multiple treatment challenges. Despite advances, glycemic control remains suboptimal, necessitating the development of treatment guidelines and metrics tailored to the South Asian population.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2022)

Article Endocrinology & Metabolism

Macronutrient Recommendations for Remission and Prevention of Diabetes in Asian Indians Based on a Data-Driven Optimization Model: The ICMR-INDIAB National Study

Ranjit Mohan Anjana, Seshadhri Srinivasan, Vasudevan Sudha, Shashank R. Joshi, Banshi Saboo, Nikhil Tandon, Ashok Kumar Das, Puthiyaveettil Kottayam Jabbar, Sri Venkata Madhu, Arvind Gupta, Sarita Bajaj, Subhankar Chowdhury, Sanjay Kalra, Rajagopal Gayathri, Kuzhandaivelu Abirami, Valangaiman Sriram Manasa, Thamotharan Padmapritha, Nagarajan Lakshmipriya, Gunasekaran Geetha, Mohan Deepa, Rajendra Pradeepa, Ranjit Unnikrishnan, Anura Viswanath Kurpad, Kamala Krishnaswamy, Tanvir Kaur, Rupinder Singh Dhaliwal, Viswanathan Mohan

Summary: A data-driven optimization approach was used to derive macronutrient recommendations for remission and prevention of type 2 diabetes in Asian Indians. Reduction in carbohydrates and an increase in protein intake were recommended for both T2D remission and for prevention of progression to T2D in prediabetes and normal glucose tolerance groups. These results highlight the importance of new dietary guidelines to address the burden of diabetes in South Asia.

DIABETES CARE (2022)

Review Multidisciplinary Sciences

Current Understanding of Diabetic Dyslipidemia: A Review

Arvind Gupta, Rajeev Gupta

Summary: Diabetes is a chronic disease associated with metabolic abnormalities and it is the principal cause of disability and deaths, especially cardiovascular diseases, which are mainly caused by lipid abnormalities. Diabetic dyslipidemia is characterized by elevated levels of small-dense LDL cholesterol and triglycerides and low levels of HDL cholesterol. High LDL cholesterol has been proven to be causative for cardiovascular disease. Treatment with statins is the main therapy, but combination therapies might be needed for high-risk individuals. Recent research has also confirmed the role of elevated triglycerides as a cardiovascular risk factor. However, currently there are limited options for drug therapy. Low HDL cholesterol seems to be less significant as a contributor to cardiovascular risk compared to its previous consideration as a risk marker. Primary prevention strategies for cardiovascular disease in diabetes should focus on risk assessment, lifestyle interventions and statin treatment.

JOURNAL OF THE INDIAN INSTITUTE OF SCIENCE (2023)

Article Endocrinology & Metabolism

Assessment of determining factors for severity of NeoCOVIDiabetes in India: A pan India multicentric retrospective study

Anuj Maheshwari, Dhruvi Hasnani, Meenakshi Bhattacharya, M. Mukhyaprana Prabhu, Divya Saxena, Bidita Khandelwal, C. L. Nawal, Brij Mohan Makkar, Sajid Ansari, Prahlad Chawla, Prabhat Agrawal, Ashish Saxena, Narsingh Verma, Banshi Saboo, Vipul Chavda, Uday Pratap Singh, Vanshika Arora

Summary: The study estimates the prevalence of newly detected diabetes patients who recovered from COVID-19 in India and compares them with patients without diabetes and those with known diabetes in terms of glycemic status and disease severity. The results show that diabetic patients had higher average blood glucose levels and a higher proportion of them required hospitalization. They also received higher doses of steroids for treatment. Further research is needed to understand the etiology, prognosis, and treatment opportunities of post-acute COVID-19 metabolism.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2023)

Review Endocrinology & Metabolism

Expert Opinion on the Diagnosis and Management of Male Hypogonadism in India

Sanjay Kalra, Jubbin Jacob, A. G. Unnikrishnan, Ganapathi Bantwal, Abhay Sahoo, Rakesh Sahay, Sushil Jindal, Madhu Sudan Agrawal, Nitin Kapoor, Banshi Saboo, Mangesh Tiwaskar, Kapil Kochhar

Summary: Male hypogonadism is a clinical and biochemical syndrome characterized by inadequate testosterone synthesis, which can lead to long-term effects on various aspects. The prevalence of male hypogonadism is high among Indian men above 40 and those with type 2 diabetes mellitus. However, underdiagnosis is common due to poor patient-physician communication. Testosterone replacement therapy is recommended for confirmed hypogonadism, but optimal treatment strategies are still a challenge.

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2023)

Review Endocrinology & Metabolism

Position of Sulfonylureas in the Current ERA: Review of National and International Guidelines

Viswanathan Mohan, Banshi Saboo, Jabbar Khader, Kirtikumar D. Modi, Sushil Jindal, Subhash Kumar Wangnoo, Sugumaran Amarnath

Summary: This article evaluates national and international guidelines for diabetes management, with a focus on the role and recommendations of sulfonylureas (SUs) in the management of type 2 diabetes mellitus (T2DM). The guidelines suggest the use of certain second-generation SUs in select populations and specific scenarios. Effective management of T2DM requires identifying appropriate populations, classifying based on underlying risk, thorough assessment of comorbid conditions, and a step-wise approach for selecting appropriate SUs. Cost-to-benefit ratio should be considered, particularly in low- and middle-income countries (LMICs), where SUs can continue to play an important role.

CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES (2022)

No Data Available